Sharon Carroll is an associate at the firm’s Nashville office. She is a member of the Health Care and FDA practice group.
Prior to joining the firm, Sharon was an associate at a prominent Nashville-based law firm where her practice focused on capital markets as well as securities law reporting and compliance matters for Nasdaq-listed companies. She was lead associate on various strategic complex transactions, including a US$20 million “mini-IPO” by medical device manufacturer and a US$40 million venture capital financing and related acquisitions by a health care technology start-up.
Before moving to Nashville, Sharon spent time overseas in Hong Kong as deal counsel for Madison Pacific Trust Limited in an array of cross-border transactions, including syndicated credit facilities, sovereign bond issuances and debt restructurings, among others, throughout the Asia-Pacific region.
- ‘The Rise of Special Purpose Acquisition Companies and “SPACulation” of What’s to Come,' ACC TN Newsletter, Fall 2021